ViroGates A/S Price (VIRO.CO)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

3,461,000

(18.0116)%

ViroGates Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

ViroGates A/S develops and markets prognostic products for the healthcare sector. It offers suPARnostic, a blood test that measures the soluble urokinase plasminogen activator receptor (suPAR) protein in the bloodstream used for emergency departments in hospitals to improve clinical decisions on hospitalization or discharge of acute medical patients and reduce healthcare cost. The company also provides suPARnostic TurbiLatex, a latex particle-enhanced turbidimetric immunoassay that quantitatively determines the suPAR level in human K2-EDTA- or lithium he... Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $5.2-31
  • Market Cap 63.04M
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Medical - Devices

  • ceo: Mr. Jakob Knudsen
  • IPO Date: June, 26, 2018
  • Country: DK
  • Currency: DKK
  • Headquaters: No Data
  • Employees: 10

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation